The role of respiratory microbiome in early bactericidal activity of anti-tuberculosis therapy and treatment outcome

Stephen Henry Gillespie (Creator)

Dataset

1 Article

1 results

2023
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials
Musisi, E., Wyness, A. J., Eldirdiri, S., Dombay, E., Mtafya, B. A., Ntinginya, N. E., Heinrich, N., Kibiki, G. S., Hoelscher, M., Boeree, M., Aarnoutse, R., Gillespie, S. H., Sabiiti, W. & PanACEA Consortium, 1 Nov 2023, In: The Lancet Microbe. 4, 11, p. E913-E922 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File